LONDON and PHOENIX, March 23, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCPink:ACUT), a life sciences company dedicated to improving outcomes for patients with cancer, is pleased to announce that its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company ("DTC") in the United States.
Read more at globenewswire.comAccuStem Sciences, Inc. Announces DTC Eligibility
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here